Nick Langhals
About Nick Langhals
Nick Langhals serves as the Supervisory Program Director at the National Institutes of Health, where he oversees projects related to neural engineering. He has extensive experience in research and development, particularly in pain treatment devices and neural interface technology.
Work at National Institutes of Health
Currently, Nick Langhals serves as a Supervisory Program Director at the National Institutes of Health (NIH) in North Bethesda, MD. He has held this position since 2018, overseeing a team of project managers responsible for a portfolio of grants that focus on neural engineering. His work includes projects related to neuroprostheses and brain-computer interface devices. Prior to this role, he was a Program Director at NIH from 2015 to 2018, where he contributed to various initiatives within the organization.
Education and Expertise
Nick Langhals holds a Ph.D. in Biomedical Engineering from the University of Michigan, where he also earned a Master of Science in Engineering (M.S.E.) in the same field. He completed his undergraduate studies in Bioengineering at Arizona State University, achieving a Bachelor of Science (B.S.). His educational background is complemented by extensive expertise in developing devices for pain treatment and neural interface technology, positioning him as a knowledgeable professional in the field.
Background
Nick Langhals has a diverse background in research and consulting, primarily at the University of Michigan. He worked there in various capacities, including Graduate Student Research Assistant, Research Lab Specialist Senior, and Assistant Research Scientist. His experience also includes roles as a Technical Consultant at Biotectix, LLC, Neuronexus Technologies, and the University of Michigan Health System. His career spans over two decades, with a strong focus on neuroengineering and medical device development.
Achievements
Throughout his career, Nick Langhals has played a key role in significant initiatives such as the HEAL and BRAIN Initiatives at the National Institute of Neurological Disorders and Stroke. His contributions have advanced the fields of neuroengineering and biotechnology, particularly in the development of medical devices. His leadership in overseeing grant portfolios has facilitated research that aims to improve pain treatment and enhance neural interface technologies.